Larynx Cancer Biomarkers - - Chromatography Online
Larynx Cancer Biomarkers

The Column
Volume 10, Issue 9, pp. 7

Photo Credit: Getty Images/Science Photo Library – PIXOLOGICSTUDIO

Over the last 30 years, the occurrence of head and neck cancer in Spain has been increasing, and now accounts for between 5–10% of malignant tumours diagnosed each year.1 In a new study published in the journal Chromatographia, solid-phase microextraction (SPME) with gas chromatography coupled to mass spectrometry (GC–MS) has been performed to identify two potential biomarkers of epidermoid laryngeal cancer, that could be used in non-invasive diagnostic testing.

Adolfo Toledano, an otolaryngologist from the Alcorcón hospital (Madrid, Spain), approached Rafael García from Rey Juan Carlos University (Madrid, Spain) with the idea of applying volatile compound analysis to the exhaled breath of patients as a method of diagnosing head and neck cancers. García told The Column: “Previously, I had been working on the detection of volatile organic compounds (VOCs) for environmental applications, and the chance to detect these organic compounds from the exhaled air of patients suffering epidermoid laryngeal carcinomas, as non-invasive biomarkers to be used in early detection of this pathology, was an outstanding challenge.”

A group of 31 volunteers were recruited for the study: 20 healthy volunteers, and 11 patients diagnosed with cancer of the larynx undergoing treatment at Alcorcón Hospital. Samples were collected from patients exhaling air after an 8 hr fast using gas sampling bags. SPME was performed to concentrate compounds within the exhaled air, before analysis using GC–MS.

The method was able to detect seven potential biomarkers that were at different concentrations between healthy and diagnosed patients. However, only two were considered to be significantly higher in late-stage cancer patients (T3) when compared with healthy or early-stage patients (T1) — ethanol and 2-butanone.

There is a note of caution from García who said: “The importance of the work is quite relative and it is important to be cautious, since the evaluated subjects are not statistically significant enough to extract definitive conclusions, and also because the more significant VOCs were detected in the later stages of the disease. However, the importance of the investigation is the concept, not only for this serious pathology but also from other neck and head prevalent diseases. I am sure that the results are widely improvable, and it will be improved.”– B.D.

1. R. García, V. Morales, and Sergio Martín, Chromatographia 77, 501–509 (2014).


blog comments powered by Disqus
LCGC E-mail Newsletters
Global E-newsletters subscribe here:



Column Watch: Ron Majors, established authority on new column technologies, keeps readers up-to-date with new sample preparation trends in all branches of chromatography and reviews developments. LATEST: When Bad Things Happen to Good Food: Applications of HPLC to Detect Food Adulteration

Perspectives in Modern HPLC: Michael W. Dong is a senior scientist in Small Molecule Drug Discovery at Genentech in South San Francisco, California. He is responsible for new technologies, automation, and supporting late-stage research projects in small molecule analytical chemistry and QC of small molecule pharmaceutical sciences. LATEST: HPLC for Characterization and Quality Control of Therapeutic Monoclonal Antibodies

MS — The Practical Art: Kate Yu brings her expertise in the field of mass spectrometry and hyphenated techniques to the pages of LCGC. In this column she examines the mass spectrometric side of coupled liquid and gas-phase systems. Troubleshooting-style articles provide readers with invaluable advice for getting the most from their mass spectrometers. LATEST: Radical Mass Spectrometry as a New Frontier for Bioanalysis

LC Troubleshooting: LC Troubleshooting sets about making HPLC methods easier to master. By covering the basics of liquid chromatography separations and instrumentation, John Dolan is able to highlight common problems and provide remedies for them. LATEST: How Much Can I Inject? Part I: Injecting in Mobile Phase

More LCGC Columnists>>

LCGC North America Editorial Advisory Board>>

LCGC Europe Editorial Advisory Board>>

LCGC Editorial Team Contacts>>

Source: The Column,
Click here